evidence_id	assertion_id	disorder_id	disorder_name	source_file	section	section_index	path	evidence_index	reference	supports	evidence_source	snippet	explanation	raw_json
2773	2647	116	Fanconi_Anemia	Fanconi_Anemia.yaml	definitions	0	evidence	0	file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md	SUPPORT	HUMAN_CLINICAL	Table 1. Manifestations that are indicators for Fanconi anemia screening.	The FA guideline explicitly defines Table 1 manifestations as indicators that should prompt FA screening.	"{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The FA guideline explicitly defines Table 1 manifestations as indicators that should prompt FA screening."", ""reference"": ""file:research/Fanconi_Anemia_Clinical_Care_Guidelines_5thEdition_web.extracted.md"", ""snippet"": ""Table 1. Manifestations that are indicators for Fanconi anemia screening."", ""supports"": ""SUPPORT""}"
5696	5535	232	Neuromyelitis Optica	Neuromyelitis_Optica.yaml	definitions	0	evidence	0	PMID:26092914	SUPPORT		The core clinical characteristics required for patients with NMOSD with AQP4-IgG include clinical syndromes or MRI findings related to optic nerve, spinal cord, area postrema, other brainstem, diencephalic, or cerebral presentations. More stringent clinical criteria, with additional neuroimaging findings, are required for diagnosis of NMOSD without AQP4-IgG or when serologic testing is unavailable.	The abstract summarizes stratified criteria and core clinical characteristics.	"{""explanation"": ""The abstract summarizes stratified criteria and core clinical characteristics."", ""reference"": ""PMID:26092914"", ""snippet"": ""The core clinical characteristics required for patients with NMOSD with AQP4-IgG include clinical syndromes or MRI findings related to optic nerve, spinal cord, area postrema, other brainstem, diencephalic, or cerebral presentations. More stringent clinical criteria, with additional neuroimaging findings, are required for diagnosis of NMOSD without AQP4-IgG or when serologic testing is unavailable."", ""supports"": ""SUPPORT""}"
7768	7513	328	Transverse Myelitis	Transverse_Myelitis.yaml	definitions	0	evidence	0	PMID:32644728	SUPPORT		Transverse myelitis (TM) is a rare, acquired focal inflammatory disorder often presenting with rapid onset weakness, sensory deficits, and bowel/bladder dysfunction.	The abstract summarizes common presenting features used here as a minimal case definition.	"{""explanation"": ""The abstract summarizes common presenting features used here as a minimal case definition."", ""reference"": ""PMID:32644728"", ""snippet"": ""Transverse myelitis (TM) is a rare, acquired focal inflammatory disorder often presenting with rapid onset weakness, sensory deficits, and bowel/bladder dysfunction."", ""supports"": ""SUPPORT""}"
